C. Morgan

First name
Middle name
Last name
Durand, A. ., Morgan, C. L., Tinsley, S. ., Hughes, E. ., McCormack, T. ., Bitchell, C. L., & Lahoz, R. . (2024). Familial hypercholesterolaemia in UK primary care: a Clinical Practice Research Datalink study of an under-recognised condition. Br J Gen Pract, 74, e174–82. http://doi.org/10.3399/bjgp.2023.0010
Morgan, C. L., Durand, A. ., McCormack, T. ., Hughes, E. ., Berni, T. R., & Lahoz, R. . (2023). Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the CPRD. BMJ Open, 13, e064541. http://doi.org/10.1136/bmjopen-2022-064541
Heywood, B. R., Morgan, C. L., Berni, T. R., Summers, D. R., Jones, B. I., Jenkins-Jones, S. ., … Currie, C. J. (2023). Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology module. PLOS Digit Health, 2, e0000310. http://doi.org/10.1371/journal.pdig.0000310
Morgan, C. L., Thomas, M. ., Ständer, S. ., Jabbar-Lopez, Z. K., Piketty, C. ., Gabriel, S. ., … Puelles, J. . (2022). Epidemiology of prurigo nodularis in England: a retrospective database analysis. Br J Dermatol. http://doi.org/10.1111/bjd.21032
Morgan, C. L., Poole, C. D., Evans, M. ., Barnett, A. H., Jenkins-Jones, S. ., & Currie, C. J. (2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034
Morgan, C. L., Jenkins-Jones, S. ., Evans, M. ., Barnett, A. H., Poole, C. D., & Currie, C. J. (2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x
Morgan, C. L., Jenkins-Jones, S. ., Currie, C. J., & Rees, D. A. (2012). Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-1690
Holden, S. E., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., Coghill, D. ., & Currie, C. J. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34
Morgan, C. L., Owens, D. R., Aubonnet, P. ., Carr, E. S., Jenkins-Jones, S. ., Poole, C. D., & Currie, C. J. (2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025
Holden, S. H., Barnett, A. H., Peters, J. R., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123